v3.26.1
CONDENSED CONSOLIDATING BALANCE SHEET AND STATEMENT OF OPERATIONS (Details) - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Total Current Liabilities $ 3,327,598 $ 2,791,297
Accumulated deficit (8,260,616) (7,740,059)
Accumulated other comprehensive income (loss) (1,278) $ 146,100
Yubo Global [Member]    
Total Current Assets 75,647  
Intercompany receivables 459,305  
Other assets 0  
Total Assets 534,952  
Total Current Liabilities 53,704  
Intercompany payables 46,249  
Other liabilities 0  
Total Liabilities 99,954  
Capital stock and additional paid in capital 878,840  
Accumulated deficit (443,842)  
Accumulated other comprehensive income (loss) 0  
Non-controlling interests 0  
Total Deficit 434,998  
Total Liabilities and Shareholders' Equity 534,952  
Investment in subsidiaries and variable interest entity (VIE) 0  
Parent Company [Member]    
Total Current Assets 583,098  
Investment in subsidiaries and variable interest entity (VIE) 0  
Intercompany receivables 0  
Other assets 89,173  
Total Assets 672,272  
Total Current Liabilities 3,327,598  
Intercompany payables 0  
Other liabilities 0  
Total Liabilities 3,327,598  
Capital stock and additional paid in capital 5,639,303  
Accumulated deficit (8,260,616)  
Accumulated other comprehensive income (loss) (1,278)  
Non-controlling interests (32,736)  
Total Deficit (2,655,327)  
Total Liabilities and Shareholders' Equity 672,272  
Yubo International Biotech Limited    
Total Current Assets 0  
Intercompany receivables 0  
Other assets 0  
Total Assets (2,181,987)  
Total Current Liabilities 0  
Intercompany payables 0  
Other liabilities 0  
Total Liabilities 0  
Capital stock and additional paid in capital 0  
Accumulated deficit (2,181,987)  
Accumulated other comprehensive income (loss) 0  
Non-controlling interests 0  
Total Deficit (2,181,987)  
Total Liabilities and Shareholders' Equity (2,181,987)  
Investment in subsidiaries and variable interest entity (VIE) (2,181,987)  
Yubo Chengdu (WFOE)    
Total Current Assets 0  
Intercompany receivables 0  
Other assets 0  
Total Assets 0  
Total Current Liabilities 0  
Intercompany payables 0  
Other liabilities 0  
Total Liabilities 0  
Capital stock and additional paid in capital 0  
Accumulated deficit 0  
Accumulated other comprehensive income (loss) 0  
Non-controlling interests 0  
Total Deficit 0  
Total Liabilities and Shareholders' Equity 0  
Investment in subsidiaries and variable interest entity (VIE) 0  
Yubo Beijing (VIE) and Subsidiaries    
Total Current Assets 507,092  
Intercompany receivables 923,595  
Other assets 89,173  
Total Assets 2,058,467  
Total Current Liabilities 3,123,894  
Intercompany payables 1,336,650  
Other liabilities 0  
Total Liabilities 4,460,544  
Capital stock and additional paid in capital 4,823,148  
Accumulated deficit (1,278)  
Accumulated other comprehensive income (loss) (7,191,211)  
Non-controlling interests (32,736)  
Total Deficit (2,402,077)  
Total Liabilities and Shareholders' Equity 2,058,467  
Investment in subsidiaries and variable interest entity (VIE) 538,607  
Eliminations    
Total Current Assets 0  
Intercompany receivables (1,382,900)  
Other assets 0  
Total Assets (669,520)  
Total Current Liabilities 0  
Intercompany payables (1,382,900)  
Other liabilities 0  
Total Liabilities (1,382,900)  
Capital stock and additional paid in capital (1,631,914)  
Accumulated deficit 2,345,294  
Accumulated other comprehensive income (loss) 0  
Non-controlling interests 0  
Total Deficit 713,380  
Total Liabilities and Shareholders' Equity (669,520)  
Investment in subsidiaries and variable interest entity (VIE) 713,380  
Platinum (Cayman Islands) and Limited Platinum HK    
Total Current Assets 359  
Intercompany receivables 0  
Other assets 0  
Total Assets 930,359  
Total Current Liabilities 150,000  
Intercompany payables 0  
Other liabilities 0  
Total Liabilities 150,000  
Capital stock and additional paid in capital 1,569,229  
Accumulated deficit (788,870)  
Accumulated other comprehensive income (loss) 0  
Non-controlling interests 0  
Total Deficit 780,359  
Total Liabilities and Shareholders' Equity 930,359  
Investment in subsidiaries and variable interest entity (VIE) $ 930,000